![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.40 | 2.30 | 2.50 | 2.40 | 2.40 | 2.40 | 203,011 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 9k | -2.04M | -0.0154 | -1.56 | 3.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/6/2024 09:50 | P9, it doesn't matter it's that you have no investment and post in all global timezones ???? | ![]() wulber | |
04/6/2024 03:19 | @Wulber Maybe someone who works with clients in different time zones. But why would it matter to you anyhow? Who cares what time someone posts? AGM end of this month, based on todays presentation looks to me that Suzy and Kevin aren't going anywhere. Shame because i genuinely thought Adrian had come on board to sort this mess, I guess the first sign was him withdrawing the requisition notice, had that remained at least Kevin would be out by now. One down. Is this a case of if you chuck a good apple into a barrel of rotten apples, the good one also goes rotten? IDK, i still hold faith he can sort it but its looking grim currently and the clocks ticking. If by the AGM end of this month, no clear steps towards finding a CEO or sorting the board positions i really think the chance of them securing the raise could be in total jeopardy. I mean who in their right mind is going to chuck more cash at this for more of the same? I just don't see it. Ideally they will need £2.5m to give any new CEO a 12 mth runway. I was working on Adrian might get away with £1.5m at 1p IF Shard can secure support and Adrian demonstrates getting cash burn back to a more manageable level, now i'm really not so sure. This now looks like a very possible risk of the cash running out and them going onto administration- He really does need to start moving fast now. Disappointing | ![]() porky9 | |
03/6/2024 14:22 | Didn’t plan on going on but only two came on including nick (fair play) Adrian confident in Ken and theorm.(June on one of the slides) When scientists talk the share price drops lol Clx001 🤷a | ![]() jasonpugh | |
03/6/2024 11:19 | 🤷a | ![]() david boomtime | |
03/6/2024 11:10 | Who sends a post at 4.14am ??? | ![]() wulber | |
02/6/2024 20:58 | Slater selling aptamer tr1. Reduces half its investment. Is it going to buy valirx. 😳 | ![]() jasonpugh | |
02/6/2024 11:25 | Oh dear 🤷a | ![]() david boomtime | |
02/6/2024 06:39 | A lot more than 3p, lol. | ![]() wulber | |
01/6/2024 13:26 | Wulber. Those figures from shard are big. Should this happen for clx then what share price would it go to ? Wow . | ![]() david boomtime | |
01/6/2024 00:10 | Adrian had a golden op to offload Kevin with the requisition notice but then withdrew it - first blunder Suzy still employed holding on in on a £180k package despite all the mistakes, should have been on gardening leave - second blunder As it stands I’m not impressed, Adrian needs to get the BOD situation sorted out.finding a CEO should be absolute priority frankly, Totally agree, nobody is going to chuck yet more cash at this for more of the same - we need changes and fast. | ![]() porky9 | |
31/5/2024 23:01 | Yes shard needs a positive note so they can get broker fees for a raise .Surely Porky they would be better off finding a decent Ceo than spending hours on a jam tomorrow note ?They don't have a cats hell of a chance of raising if SuZy is still Ceo .Change is needed ..." tomorrow " at the latest . Good luck Wulber I hope these are 20p for you as you've been a patient loyal shareholder. Pleased you got and like the note Have a great weekend | ![]() nico115 | |
31/5/2024 22:46 | Also do you not realise why Shard might be sending out a broker note - watch this space - raise 16 will be in play soon if They can secure support | ![]() porky9 | |
31/5/2024 21:13 | Thanks mate and got it! Cheers"Following a review of recent deals in the oncology preclinical, we estimate that the median upfront payment for a preclinicalprogramme is $40m, together with potential milestones of $825m."??? | ![]() wulber | |
31/5/2024 20:36 | A link David? | ![]() wulber | |
31/5/2024 13:51 | INDI Indus gas about to move big time | ![]() kirk 6 | |
31/5/2024 13:25 | Shard capital just published a research tree note 39 pages on valirx. Exciting times ahead. 💃 | ![]() david boomtime | |
31/5/2024 12:19 | Yes it makes economic sense to take 301 too. | ![]() wulber | |
31/5/2024 12:18 | P9 - there is no placing now, stop it! | ![]() wulber | |
30/5/2024 22:10 | Could theorm take 301 aswell as 201? Mode of action similar according to data. Must admit though that 201 is spud gun clx in hypersonic weapon💃 | ![]() david boomtime | |
30/5/2024 20:29 | Even better buying opportunity in a few weeks time at the 1p Placing. Either that or bust if Adrian doesn’t get a move on and drain that swamp @David Boomtime; Jason you are having a bloody laugh, you are the biggest swing traders I have ever come across - you are fooling none of us.. | ![]() porky9 | |
30/5/2024 17:49 | Me too, sort of written off 201 but at the same time VAL reiterate THX LOI in place and are coming, but CLX could be massive!3p! Now!! FFS a steal and where l was several years ago before shooting to double figures, so another bite of the cherry.NAI, imho and DYOR | ![]() wulber | |
30/5/2024 14:30 | Looking at timeline for mergers. According to investopedia it can take between 6 months and several years to complete. With euda the us firm and theorm it’s been coming up 8 months. I’ve invested primarily for clx not 201 so this wait is irrelevant to my investment strategy. However if 201 comes through it will be bonus.💃 | ![]() david boomtime |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions